These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28871352)

  • 1. Co-operative intra-protein structural response due to protein-protein complexation revealed through thermodynamic quantification: study of MDM2-p53 binding.
    Samanta S; Mukherjee S
    J Comput Aided Mol Des; 2017 Oct; 31(10):891-903. PubMed ID: 28871352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations.
    Yadahalli S; Li J; Lane DP; Gosavi S; Verma CS
    Sci Rep; 2017 Nov; 7(1):15600. PubMed ID: 29142290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Adaptation of Secondary p53 Binding Sites on MDM2 and MDMX.
    Higbee PS; Dayhoff GW; Anbanandam A; Varma S; Daughdrill G
    J Mol Biol; 2024 Jul; 436(13):168626. PubMed ID: 38810774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates binding.
    Dastidar SG; Lane DP; Verma CS
    Cell Cycle; 2012 Jun; 11(12):2239-47. PubMed ID: 22617389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: molecular dynamics simulation and free energy analysis.
    Chen J; Wang J; Xu B; Zhu W; Li G
    J Mol Graph Model; 2011 Sep; 30():46-53. PubMed ID: 21764342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and sequential context of p53: A review of experimental and theoretical evidence.
    Saha T; Kar RK; Sa G
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):250-263. PubMed ID: 25550083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
    Pantelopulos GA; Mukherjee S; Voelz VA
    Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entropy localization in proteins.
    Li DW; Showalter SA; Brüschweiler R
    J Phys Chem B; 2010 Dec; 114(48):16036-44. PubMed ID: 21077640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.
    Dastidar SG; Lane DP; Verma CS
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S6. PubMed ID: 19958516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.
    Lee HJ; Srinivasan D; Coomber D; Lane DP; Verma CS
    Cell Cycle; 2007 Nov; 6(21):2604-11. PubMed ID: 17957142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.
    Goyal S; Grover S; Dhanjal JK; Tyagi C; Goyal M; Grover A
    J Mol Graph Model; 2014 Jun; 51():64-72. PubMed ID: 24858256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
    Verkhivker GM
    PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
    Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
    Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the conformational transitions of MDM2 and MDMX: insights into key residues affecting p53 recognition.
    Carotti A; Macchiarulo A; Giacchè N; Pellicciari R
    Proteins; 2009 Nov; 77(3):524-35. PubMed ID: 19507240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2.
    Grässlin A; Amoreira C; Baldridge KK; Robinson JA
    Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition.
    Macchiarulo A; Giacchè N; Carotti A; Baroni M; Cruciani G; Pellicciari R
    J Chem Inf Model; 2008 Oct; 48(10):1999-2009. PubMed ID: 18826207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the origin of structural stability of single and double stapled p53 peptide analogs bound to MDM2.
    Guo Z; Streu K; Krilov G; Mohanty U
    Chem Biol Drug Des; 2014 Jun; 83(6):631-42. PubMed ID: 24418072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition Dynamics of p53 and MDM2: Implications for Peptide Design.
    ElSawy KM; Lane DP; Verma CS; Caves LS
    J Phys Chem B; 2016 Jan; 120(2):320-8. PubMed ID: 26701330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53.
    Zondlo SC; Lee AE; Zondlo NJ
    Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.